
### [NCIT:C27825](http://purl.obolibrary.org/obo/NCIT_C27825)
**Label:** Mucin-Producing Carcinoma

**Subclasses:** [NCIT:C27379](http://purl.obolibrary.org/obo/NCIT_C27379) (Mucin-Producing Adenocarcinoma), [NCIT:C6457](http://purl.obolibrary.org/obo/NCIT_C6457) (Thymic Mucoepidermoid Carcinoma), [NCIT:C5862](http://purl.obolibrary.org/obo/NCIT_C5862) (Extrahepatic Bile Duct Mucoepidermoid Carcinoma), [NCIT:C8019](http://purl.obolibrary.org/obo/NCIT_C8019) (High Grade Salivary Gland Mucoepidermoid Carcinoma), [NCIT:C6018](http://purl.obolibrary.org/obo/NCIT_C6018) (Paranasal Sinus Mucoepidermoid Carcinoma), [NCIT:C4472](http://purl.obolibrary.org/obo/NCIT_C4472) (Mucoepidermoid Skin Carcinoma), [NCIT:C5166](http://purl.obolibrary.org/obo/NCIT_C5166) (Mucoepidermoid Breast Carcinoma), [NCIT:C8215](http://purl.obolibrary.org/obo/NCIT_C8215) (Recurrent Oral Cavity Mucoepidermoid Carcinoma), [NCIT:C45544](http://purl.obolibrary.org/obo/NCIT_C45544) (Lung Mucoepidermoid Carcinoma), [NCIT:C5343](http://purl.obolibrary.org/obo/NCIT_C5343) (Esophageal Mucoepidermoid Carcinoma), [NCIT:C5167](http://purl.obolibrary.org/obo/NCIT_C5167) (High Grade Mucoepidermoid Breast Carcinoma), [NCIT:C8015](http://purl.obolibrary.org/obo/NCIT_C8015) (Low Grade Salivary Gland Mucoepidermoid Carcinoma), [NCIT:C5168](http://purl.obolibrary.org/obo/NCIT_C5168) (Low Grade Mucoepidermoid Breast Carcinoma), [NCIT:C8199](http://purl.obolibrary.org/obo/NCIT_C8199) (Stage I Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7), [NCIT:C8177](http://purl.obolibrary.org/obo/NCIT_C8177) (Oral Cavity Mucoepidermoid Carcinoma), [NCIT:C6250](http://purl.obolibrary.org/obo/NCIT_C6250) (Anterior Tongue Mucoepidermoid Carcinoma), [NCIT:C8178](http://purl.obolibrary.org/obo/NCIT_C8178) (Floor of Mouth Mucoepidermoid Carcinoma), [NCIT:C8211](http://purl.obolibrary.org/obo/NCIT_C8211) (Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7), [NCIT:C9463](http://purl.obolibrary.org/obo/NCIT_C9463) (Laryngeal Mucoepidermoid Carcinoma), [NCIT:C38762](http://purl.obolibrary.org/obo/NCIT_C38762) (Thyroid Gland Mucoepidermoid Carcinoma), [NCIT:C5908](http://purl.obolibrary.org/obo/NCIT_C5908) (Salivary Gland Mucoepidermoid Carcinoma), [NCIT:C5906](http://purl.obolibrary.org/obo/NCIT_C5906) (Major Salivary Gland Mucoepidermoid Carcinoma), [NCIT:C3772](http://purl.obolibrary.org/obo/NCIT_C3772) (Mucoepidermoid Carcinoma), [NCIT:C8207](http://purl.obolibrary.org/obo/NCIT_C8207) (Stage III Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7), [NCIT:C5953](http://purl.obolibrary.org/obo/NCIT_C5953) (Minor Salivary Gland Mucoepidermoid Carcinoma), [NCIT:C8203](http://purl.obolibrary.org/obo/NCIT_C8203) (Stage II Oral Cavity Mucoepidermoid Carcinoma), [NCIT:C6091](http://purl.obolibrary.org/obo/NCIT_C6091) (Lacrimal Gland Mucoepidermoid Carcinoma), [NCIT:C5938](http://purl.obolibrary.org/obo/NCIT_C5938) (Parotid Gland Mucoepidermoid Carcinoma), [NCIT:C5939](http://purl.obolibrary.org/obo/NCIT_C5939) (Submandibular Gland Mucoepidermoid Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.40%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40395](http://purl.obolibrary.org/obo/NCIT_C40395) (Malignant Breast Myoepithelioma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40388](http://purl.obolibrary.org/obo/NCIT_C40388) (Periductal Breast Myoepitheliosis))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40384](http://purl.obolibrary.org/obo/NCIT_C40384) (Breast Ductal Adenoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40383](http://purl.obolibrary.org/obo/NCIT_C40383) (Breast Apocrine Adenoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40379](http://purl.obolibrary.org/obo/NCIT_C40379) (Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40378](http://purl.obolibrary.org/obo/NCIT_C40378) (Post-Radiotherapy Breast Angiosarcoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40377](http://purl.obolibrary.org/obo/NCIT_C40377) (Breast Follicular Lymphoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40366](http://purl.obolibrary.org/obo/NCIT_C40366) (Oncocytic Breast Carcinoma))) 40.91%


